Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients
Titel:
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients
Auteur:
Winkelmayer, Wolfgang C. Arnold, Susan Burke, Steven K. Chertow, Glenn M. Eckardt, Kai-Uwe Jardine, Alan G. Lewis, Eldrin F. Luo, Wenli Matsushita, Kunihiro McCullough, Peter A. Minga, Todd Parfrey, Patrick S.